Novartis Venture Funds targets innovative life science companies with a primary focus on the development of novel therapeutics and platforms. The firm prefers initial investment at the early stage to build the company and follow with additional investments in line with progress. With the growth of the biotech industry, the Novartis Venture Fund has been active in supporting areas of the Novartis franchises.In 2015, Qualcomm Ventures and Novartis Venture Funds established a joint investment company, dRx Capital, with up to USD 100 million to support early stage companies with technologies, products and services.
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.